Distinguished Delaware physicians, scientists and entrepreneurs met with colleagues from around the world at the University of Delaware’s STAR campus to discuss exciting work being done in the fields of translational medicine and oncology research here in the State.

Members of the international bio-science community will met with Governor Jack Markell, followed by a lively discussion with area experts to learn about ground-breaking work being done here in the search for tests, tools and treatment that can be used to combat diseases such as cancer. They also took a tour of the state-of-the-art facilities at UD’s STAR campus and heard details about the wet lab incubators under construction at UD and at Delaware State University.

“Delaware is committed to providing companies with the support and resources needed to convert research into results that can be used to detect disease, equip caregivers and provide patients with treatment and therapies,” said Governor Jack Markell. “Our small state makes it easier for researchers to connect with community healthcare facilities and accomplished healthcare providers to accelerate the pace of moving medicines, equipment and therapies from the lab bench to the patient’s bedside.”

The event featured some of the brightest minds in the State, including scientists from the Center for Translational Cancer Research and DSU’s Optical Science Center for Applied Research, as well as executives from bio-science start-ups Genome Profiling and Incyte and from Delaware Technology Park. Industry veteran Ian Wright and Dean of UD’s College of Health Sciences Kathleen Matt are hosted the event.

“This is a unique opportunity for international bio-science executives and scientists to connect with an exceptional group of professionals doing cutting-edge research, and to appreciate how Delaware provides the perfect environment for this caliber of work,” said Ian Wright. “We are confident that we will provide our colleagues from with serious food for thought as they contemplate the best place in the U.S. to bring their bio-science business.” Read more —news.delaware.gov

Skip to content